INTERNATIONAL PATENT: VACCINEX, INC., MSD INTERNATIONAL GMBH FILES APPLICATION FOR "USE OF PD-L1 LOW EXPRESSION STATUS TO SELECT SUBJECTS FOR CANCER IMMUNOTHERAPY"

GENEVA, Feb. 18 -- VACCINEX, INC. (1895 Mount Hope AvenueRochester, New York 14620), MSD INTERNATIONAL GMBH (Weystrasse 206006 Luzern) filed a patent application (PCT/US2024/041765) for "USE OF PD-L1 LOW EXPRESSION STATUS TO SELECT SUBJECTS FOR CANCER IMMUNOTHERAPY" on Aug 09, 2024. With publication no. WO/2025/035118, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EVANS, Elizabeth (14 Main StreetBloomfield, New York 14586), ZAUDERER, Maurice (44 Woodland RoadPittsford, New York 14534), FISHER, Terry (c/o Vaccinex Inc.18...